| Business Summary | | Techne
Corporation
is
a
holding
company
that
has
two
wholly
owned
operating
subsidiaries,
Research
and
Diagnostic
Systems,
Inc.
(R&D
Systems)
and
R&D
Systems
Europe
Ltd.
(R&D
Europe)
R&D
Systems
is
a
specialty
manufacturer
of
biological
products.
Its
two
major
operating
segments
are
hematology
controls,
which
are
used
in
hospital
and
clinical
laboratories
to
check
the
accuracy
of
blood
analysis
instruments,
biotechnology
products
including
purified
proteins
(cytokines)
and
antibodies,
which
are
sold
exclusively
to
the
research
market,
and
assay
kits,
which
are
sold
to
the
research
and
clinical
diagnostic
markets.
R&D
Europe
distributes
R&D
Systems'
biotechnology
products
in
Europe.
R&D
Europe
has
a
German
sales
subsidiary,
R&D
Systems
GmbH.
The
Company
also
has
a
foreign
sales
corporation,
Techne
Export
Inc. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Techne
Corp.,
is
engaged
domestically
in
the
development
and
manufacture
of
biotechnology
products
and
hematology
calibrators
and
controls
which
are
distributed
throughout
Europe.
For
the
nine
months
ended
3/31/01,
net
sales
rose
11%
to
$84.7
million.
Net
income
rose
36%
to
$24.7
million.
Revenues
reflect
increased
sales
from
the
Biotechnology
and
Hematology
divisions.
Earnings
also
benefitted
from
favorable
exchange
effects
and
a
one-time
tax
credit. Recent Earnings Announcement For
the
3
months
ended
06/30/2001,
revenues
were
30,705;
after
tax
earnings
were
9,395. (Preliminary; reported in thousands of dollars.) | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Thomas Oland, 59 Chairman,
Pres, Treasurer | $230K | $273K | Roger Lucas, Ph.D., 57 Vice
Chairman | -- | -- | Timothy Heaney, 54 VP,
Sec., Gen. Counsel, Director | 152K | 505K | Monica Tsang, Ph.D., 55 VP
of Research | 236K | 533K | Marcel Veronneau, 45 VP
of Hematology Operations | 148K | 642K | Dollar
amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|